Investor Broadrick Dale
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Broadrick Dale . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2024-03-06 13D/A BRTX / BioRestorative Therapies, Inc. 23,817,951 926,376
2022-06-21 13D/A BRTX / BioRestorative Therapies, Inc. 570,184 611,745
2022-04-14 13G KNW / Know Labs, Inc. 1,768,087 1,752,040
2022-04-07 13D/A / Biorestorative Therapies Inc 508,484 570,184
2022-03-29 13D/A / Biorestorative Therapies Inc 508,484
2020-01-09 13D/A BRTX / BioRestorative Therapies, Inc. 15,357,741 23,817,951
2019-12-10 13D/A BRTX / BioRestorative Therapies, Inc. 13,268,889 15,357,741
2019-11-01 13D/A BRTX / BioRestorative Therapies, Inc. 12,859,176 13,268,889
2019-10-18 13D/A BRTX / BioRestorative Therapies, Inc. 5,550,623 12,859,176
2019-05-09 13D/A BRTX / BioRestorative Therapies, Inc. 3,161,452 5,550,623
2019-03-01 13D BRTX / BioRestorative Therapies, Inc. 3,161,452
2016-08-31 13D/A KNWN / Know Labs, Inc. 1,768,087
2016-08-31 13D/A KNWN / Know Labs, Inc. 310,165 1,768,087
2016-06-20 13D KNWN / Know Labs, Inc. 310,165
2016-06-20 13D KNWN / Know Labs, Inc. 310,165